An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post Traumatic Stress Disorder

Phase 2

Completed

• Conditions: Post Traumatic stress Disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12605000322639
• Lead Sponsor: Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

PTSD according to DSM-IV criteria and a baseline CAPS 2 score greater than 50.

Exclusion Criteria

Current substance use disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in CAPS2 score from baseline over 8 weeks treatment[At the end of the study.]

Secondary Outcome Measures

Name	Time	Method
Change in HAM-D, CGI, PCL, AUDIT and DAR scores over same time period.[At the end of the study.]